Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/17/25
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 09/15/23
End: 10/31/28
Due: 10/31/29
Phase: N/A
Priority: Normal
Start: 11/11/24
End: 04/30/33
Due: 04/30/34
Phase: N/A
Priority: Normal
Start: 07/14/22
End: 02/28/29
Due: 02/28/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | NCT06517888 | Akouos, Inc. | user2@example.com | None | 2025-01-17 | 2029-08-31 | 2030-08-31 | - | - | 2025-07-14 |
| Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss | NCT05821959 | Akouos, Inc. | user2@example.com | None | 2023-09-15 | 2028-10-31 | 2029-10-31 | - | - | 2025-07-14 |
| Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | NCT06696456 | Akouos, Inc. | user2@example.com | None | 2024-11-11 | 2033-04-30 | 2034-04-30 | - | - | 2025-07-14 |
| Otoferlin Gene-mediated Hearing Loss Natural History Study | NCT05572073 | Akouos, Inc. | user2@example.com | None | 2022-07-14 | 2029-02-28 | 2030-02-28 | - | - | 2025-07-14 |